PMC:7461420 / 75889-81452
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T272 | 246-254 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
T273 | 447-451 | Body_part | denotes | gene | http://purl.org/sig/ont/fma/fma74402 |
T274 | 574-582 | Body_part | denotes | cysteine | http://purl.org/sig/ont/fma/fma82751 |
T275 | 1788-1793 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T276 | 2248-2252 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T277 | 2538-2543 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T278 | 2963-2967 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T279 | 3172-3176 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T280 | 3444-3448 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T281 | 5471-5479 | Body_part | denotes | cysteine | http://purl.org/sig/ont/fma/fma82751 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T363 | 890-894 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T364 | 1018-1021 | Disease | denotes | HTS | http://purl.obolibrary.org/obo/MONDO_0011549 |
T365 | 1113-1117 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T366 | 1836-1840 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T367 | 1924-1928 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T368 | 1934-1967 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T369 | 2465-2469 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T370 | 3426-3430 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T371 | 3545-3548 | Disease | denotes | HTS | http://purl.obolibrary.org/obo/MONDO_0011549 |
T372 | 3627-3631 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T373 | 3818-3822 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T374 | 3882-3886 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T375 | 4111-4115 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T376 | 4121-4154 | Disease | denotes | severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T377 | 4239-4243 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T378 | 4472-4476 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T379 | 4553-4557 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T380 | 4675-4679 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T381 | 4755-4759 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T382 | 4969-4973 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T383 | 5141-5145 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T384 | 5250-5254 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
T385 | 5380-5384 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T901 | 447-451 | http://purl.obolibrary.org/obo/OGG_0000000002 | denotes | gene |
T902 | 572-573 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T903 | 600-606 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
T904 | 621-622 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T905 | 692-693 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T906 | 721-722 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T907 | 992-994 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
T908 | 1025-1026 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T909 | 1122-1126 | http://purl.obolibrary.org/obo/CLO_0001757 | denotes | 1 at |
T910 | 1127-1128 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T911 | 1234-1235 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T912 | 1616-1624 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T913 | 1661-1662 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T914 | 1698-1699 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T915 | 1771-1779 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T916 | 1783-1787 | http://purl.obolibrary.org/obo/CLO_0009524 | denotes | Vero |
T917 | 1783-1787 | http://purl.obolibrary.org/obo/CLO_0050515 | denotes | Vero |
T918 | 1788-1793 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T919 | 1832-1834 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
T920 | 2155-2158 | http://purl.obolibrary.org/obo/CLO_0001003 | denotes | 163 |
T921 | 2204-2207 | http://purl.obolibrary.org/obo/CLO_0001003 | denotes | 163 |
T922 | 2248-2252 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T923 | 2270-2273 | http://purl.obolibrary.org/obo/CLO_0001003 | denotes | 163 |
T924 | 2308-2318 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
T925 | 2453-2461 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T926 | 2506-2514 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T927 | 2533-2537 | http://purl.obolibrary.org/obo/CLO_0009524 | denotes | Vero |
T928 | 2533-2537 | http://purl.obolibrary.org/obo/CLO_0050515 | denotes | Vero |
T929 | 2538-2543 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T930 | 2592-2593 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T931 | 2723-2724 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T932 | 2937-2945 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T933 | 2963-2967 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T934 | 3043-3051 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T935 | 3096-3104 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T936 | 3172-3176 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T937 | 3219-3221 | http://purl.obolibrary.org/obo/CLO_0001313 | denotes | 36 |
T938 | 3253-3263 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
T939 | 3384-3392 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T940 | 3435-3448 | http://purl.obolibrary.org/obo/CLO_0001757 | denotes | 1 in the cell |
T941 | 3552-3553 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T942 | 3620-3621 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T943 | 3865-3866 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T944 | 3929-3934 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T945 | 4287-4288 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T946 | 4520-4521 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T947 | 4551-4552 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T948 | 5027-5030 | http://purl.obolibrary.org/obo/CLO_0001180 | denotes | 203 |
T949 | 5081-5089 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T950 | 5119-5120 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T951 | 5291-5292 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T952 | 5353-5355 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
T953 | 5378-5379 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T954 | 5459-5465 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T82062 | 23-33 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T21071 | 246-254 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T24059 | 425-435 | Chemical | denotes | interferon | http://purl.obolibrary.org/obo/CHEBI_52999 |
T54555 | 540-554 | Chemical | denotes | antiviral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
T42980 | 540-549 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T18720 | 550-554 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T6945 | 574-582 | Chemical | denotes | cysteine | http://purl.obolibrary.org/obo/CHEBI_15356 |
T3561 | 694-705 | Chemical | denotes | nucleophile | http://purl.obolibrary.org/obo/CHEBI_59740 |
T22358 | 731-735 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T29111 | 736-740 | Chemical | denotes | base | http://purl.obolibrary.org/obo/CHEBI_22695 |
T41910 | 816-819 | Chemical | denotes | Cys | http://purl.obolibrary.org/obo/CHEBI_15356|http://purl.obolibrary.org/obo/CHEBI_17561|http://purl.obolibrary.org/obo/CHEBI_29950 |
T437 | 820-822 | Chemical | denotes | SH | http://purl.obolibrary.org/obo/CHEBI_29312|http://purl.obolibrary.org/obo/CHEBI_73651 |
T21797 | 907-917 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T17235 | 931-942 | Chemical | denotes | naphthalene | http://purl.obolibrary.org/obo/CHEBI_16482 |
T55336 | 957-971 | Chemical | denotes | lead compounds | http://purl.obolibrary.org/obo/CHEBI_33585 |
T442 | 1269-1278 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T41674 | 1311-1326 | Chemical | denotes | racemic mixture | http://purl.obolibrary.org/obo/CHEBI_60911 |
T43552 | 1319-1326 | Chemical | denotes | mixture | http://purl.obolibrary.org/obo/CHEBI_60004 |
T96618 | 1520-1526 | Chemical | denotes | methyl | http://purl.obolibrary.org/obo/CHEBI_32875|http://purl.obolibrary.org/obo/CHEBI_29309 |
T72348 | 1533-1545 | Chemical | denotes | amino groups | http://purl.obolibrary.org/obo/CHEBI_51142 |
T21234 | 1533-1538 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T15943 | 1560-1566 | Chemical | denotes | phenyl | http://purl.obolibrary.org/obo/CHEBI_30396 |
T58369 | 1761-1770 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T22446 | 1853-1863 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T452 | 1873-1884 | Chemical | denotes | naphthalene | http://purl.obolibrary.org/obo/CHEBI_16482 |
T453 | 2056-2061 | Chemical | denotes | amide | http://purl.obolibrary.org/obo/CHEBI_29337|http://purl.obolibrary.org/obo/CHEBI_32988 |
T59470 | 2062-2064 | Chemical | denotes | NH | http://purl.obolibrary.org/obo/CHEBI_29339|http://purl.obolibrary.org/obo/CHEBI_73424 |
T85501 | 2107-2116 | Chemical | denotes | benzamide | http://purl.obolibrary.org/obo/CHEBI_28179 |
T21639 | 2259-2268 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T23665 | 2335-2340 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T51563 | 2496-2505 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T1863 | 2697-2709 | Chemical | denotes | methyl group | http://purl.obolibrary.org/obo/CHEBI_32875 |
T25019 | 2697-2703 | Chemical | denotes | methyl | http://purl.obolibrary.org/obo/CHEBI_29309 |
T26688 | 2704-2709 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T68003 | 2803-2809 | Chemical | denotes | methyl | http://purl.obolibrary.org/obo/CHEBI_32875|http://purl.obolibrary.org/obo/CHEBI_29309 |
T37926 | 2810-2820 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T24619 | 3283-3289 | Chemical | denotes | fluoro | http://purl.obolibrary.org/obo/CHEBI_42645 |
T84377 | 3302-3311 | Chemical | denotes | benzamide | http://purl.obolibrary.org/obo/CHEBI_28179 |
T85927 | 3580-3589 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
T90186 | 3694-3703 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T3146 | 4047-4057 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T97002 | 4195-4205 | Chemical | denotes | thiopurine | http://purl.obolibrary.org/obo/CHEBI_35666 |
T30860 | 4256-4266 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T25638 | 4327-4345 | Chemical | denotes | thiocarbonyl group | http://purl.obolibrary.org/obo/CHEBI_30256 |
T11104 | 4340-4345 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T92852 | 4413-4430 | Chemical | denotes | anticancer agents | http://purl.obolibrary.org/obo/CHEBI_35610 |
T477 | 4570-4579 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T95879 | 4628-4633 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
T71817 | 4649-4665 | Chemical | denotes | diarylheptanoids | http://purl.obolibrary.org/obo/CHEBI_78802 |
T31826 | 4742-4751 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T66600 | 4819-4827 | Chemical | denotes | carbonyl | http://purl.obolibrary.org/obo/CHEBI_23019 |
T28022 | 4896-4905 | Chemical | denotes | flavonoid | http://purl.obolibrary.org/obo/CHEBI_47916|http://purl.obolibrary.org/obo/CHEBI_72544 |
T44605 | 5093-5104 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
T3152 | 5329-5339 | Chemical | denotes | Disulfiram | http://purl.obolibrary.org/obo/CHEBI_4659 |
T19310 | 5397-5406 | Chemical | denotes | inhibitor | http://purl.obolibrary.org/obo/CHEBI_35222 |
T78735 | 5471-5479 | Chemical | denotes | cysteine | http://purl.obolibrary.org/obo/CHEBI_15356 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T68 | 144-161 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
T69 | 144-161 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
T70 | 325-342 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
T71 | 325-342 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
T72 | 387-403 | http://purl.obolibrary.org/obo/GO_0016579 | denotes | deubiquitinating |
T73 | 492-514 | http://purl.obolibrary.org/obo/GO_0045087 | denotes | innate immune response |
T74 | 499-514 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
T75 | 3958-3988 | http://purl.obolibrary.org/obo/GO_0004843 | denotes | ubiquitin C‐terminal hydrolase |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2385 | 5-16 | Species | denotes | Coronavirus | Tax:11118 |
2390 | 49-53 | Gene | denotes | Mpro | Gene:8673700 |
2391 | 256-260 | Gene | denotes | nsp1 | Gene:10045 |
2392 | 261-265 | Gene | denotes | nsp3 | Gene:10044 |
2393 | 283-287 | Gene | denotes | nsp3 | Gene:10044 |
2404 | 574-591 | Gene | denotes | cysteine protease | Gene:1508 |
2405 | 652-658 | Chemical | denotes | Cys112 | |
2406 | 659-665 | Chemical | denotes | His273 | |
2407 | 666-672 | Chemical | denotes | Asp287 | |
2408 | 674-680 | Chemical | denotes | Cys112 | |
2409 | 711-717 | Chemical | denotes | His273 | |
2410 | 742-748 | Chemical | denotes | Asp287 | |
2411 | 755-761 | Chemical | denotes | His273 | |
2412 | 797-800 | Chemical | denotes | His | MESH:D006639 |
2413 | 816-819 | Chemical | denotes | Cys | MESH:D003545 |
2418 | 890-898 | Species | denotes | SARS‐CoV | Tax:694009 |
2419 | 1113-1121 | Species | denotes | SARS‐CoV | Tax:694009 |
2420 | 1345-1348 | Species | denotes | SAR | Tax:2698737 |
2421 | 931-942 | Chemical | denotes | naphthalene | MESH:C031721 |
2426 | 1902-1922 | Gene | denotes | papain‐like protease | |
2427 | 1836-1844 | Species | denotes | SARS‐CoV | Tax:694009 |
2428 | 1924-1932 | Species | denotes | SARS‐CoV | Tax:694009 |
2429 | 1873-1884 | Chemical | denotes | naphthalene | MESH:C031721 |
2432 | 2056-2061 | Chemical | denotes | amide | MESH:D000577 |
2433 | 2107-2116 | Chemical | denotes | benzamide | MESH:C037689 |
2436 | 2465-2473 | Species | denotes | SARS‐CoV | Tax:694009 |
2437 | 2633-2638 | Chemical | denotes | PLpro | |
2440 | 3426-3434 | Species | denotes | SARS‐CoV | Tax:694009 |
2441 | 3281-3311 | Chemical | denotes | m‐fluoro‐substituted benzamide | |
2452 | 3958-3988 | Gene | denotes | ubiquitin C‐terminal hydrolase | Gene:7345 |
2453 | 3991-3998 | Gene | denotes | hUCH‐L1 | Gene:7345 |
2454 | 4005-4012 | Gene | denotes | hUCH‐L3 | Gene:7347 |
2455 | 3627-3635 | Species | denotes | SARS‐CoV | Tax:694009 |
2456 | 3664-3672 | Species | denotes | MERS‐CoV | Tax:1335626 |
2457 | 3764-3772 | Species | denotes | MERS‐CoV | Tax:1335626 |
2458 | 3818-3826 | Species | denotes | SARS‐CoV | Tax:694009 |
2459 | 3882-3890 | Species | denotes | SARS‐CoV | Tax:694009 |
2460 | 3903-3911 | Species | denotes | MERS‐CoV | Tax:1335626 |
2461 | 3929-3934 | Species | denotes | human | Tax:9606 |
2464 | 4089-4109 | Gene | denotes | papain‐like protease | |
2465 | 4111-4119 | Species | denotes | SARS‐CoV | Tax:694009 |
2470 | 4239-4247 | Species | denotes | SARS‐CoV | Tax:694009 |
2471 | 4195-4205 | Chemical | denotes | thiopurine | |
2472 | 4216-4229 | Chemical | denotes | 6‐thioguanine | MESH:D013866 |
2473 | 4395-4403 | Disease | denotes | toxicity | MESH:D064420 |
2480 | 4553-4561 | Species | denotes | SARS‐CoV | Tax:694009 |
2481 | 4675-4683 | Species | denotes | SARS‐CoV | Tax:694009 |
2482 | 4755-4763 | Species | denotes | SARS‐CoV | Tax:694009 |
2483 | 4969-4977 | Species | denotes | SARS‐CoV | Tax:694009 |
2484 | 4522-4532 | Chemical | denotes | tanshinone | MESH:C021751 |
2485 | 4896-4905 | Chemical | denotes | flavonoid | MESH:D005419 |
2492 | 5119-5132 | Species | denotes | B. Papyrifera | Tax:172644 |
2493 | 5141-5149 | Species | denotes | SARS‐CoV | Tax:694009 |
2494 | 5160-5168 | Species | denotes | MERS‐CoV | Tax:1335626 |
2495 | 5250-5258 | Species | denotes | SARS‐CoV | Tax:694009 |
2496 | 5271-5279 | Species | denotes | MERS‐CoV | Tax:1335626 |
2497 | 5093-5104 | Chemical | denotes | polyphenols | MESH:D059808 |
2501 | 5380-5388 | Species | denotes | SARS‐CoV | Tax:694009 |
2502 | 5329-5339 | Chemical | denotes | Disulfiram | MESH:D004221 |
2503 | 5471-5479 | Chemical | denotes | cysteine | MESH:D003545 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T656 | 0-33 | Sentence | denotes | 3.2 Coronavirus PLpro inhibitors |
T657 | 34-162 | Sentence | denotes | Along with the Mpro, papain‐like protease (PLpro) also cleaves polyproteins which is an important process for viral replication. |
T658 | 163-267 | Sentence | denotes | PLpro cleaves at the first three positions creating three nonstructural functional proteins (nsp1‐nsp3). |
T659 | 268-351 | Sentence | denotes | In particular, nsp3 is central for the generation of the viral replication complex. |
T660 | 352-562 | Sentence | denotes | The multifunctionality of PLpro in deubiquitinating, de‐ISGylation (ISG: interferon‐stimulated gene), 195 , 196 and in the evasion of the innate immune response make PLpro an attractive antiviral drug target. |
T661 | 563-673 | Sentence | denotes | PLpro is a cysteine protease and its active site contains a catalytic triad composing of Cys112‐His273‐Asp287. |
T662 | 674-741 | Sentence | denotes | Cys112 behaves as a nucleophile, and His273 is a general acid‐base. |
T663 | 742-823 | Sentence | denotes | Asp287 helps His273 to align perfectly, thus promoting His to deprotonate Cys‐SH. |
T664 | 824-836 | Sentence | denotes | Ghosh et al. |
T665 | 837-952 | Sentence | denotes | 197 contributed significantly to the development of SARS‐CoV‐1 PLpro inhibitors based on the naphthalene scaffold. |
T666 | 953-1085 | Sentence | denotes | Two lead compounds 157 and 158 (Figure 36) were identified by an HTS of a chemical library containing greater than 50 000 compounds. |
T667 | 1086-1182 | Sentence | denotes | They both inhibit PLpro of SARS‐CoV‐1 at a moderate potency (IC50 20.1 and 59 µM, respectively). |
T668 | 1183-1333 | Sentence | denotes | The (R)‐enantiomer of compound 157 was found to be a greater than twofold more potent inhibitor of PLpro when compared with its racemic mixture (157). |
T669 | 1334-1572 | Sentence | denotes | Subsequent SAR studies highlighted the 2‐naphthyl substitution as an important structural requirement rather than at the position 1 of the naphthyl ring in addition to the presence of o‐methyl and m‐amino groups, in the other phenyl ring. |
T670 | 1573-1721 | Sentence | denotes | Compound 159 displayed the best inhibitory activity of PLpro (IC50, 0.6 µM) and acts in a noncovalent reversible manner with a K i value of 0.49 µM. |
T671 | 1722-1824 | Sentence | denotes | 198 Compound 159 also showed moderate antiviral activity in Vero cells with an EC50 value of 14.5 µM. |
T672 | 1825-1894 | Sentence | denotes | Figure 36 SARS‐CoV‐1 PLpro inhibitors based on naphthalene scaffold. |
T673 | 1895-2132 | Sentence | denotes | PLpro, papain‐like protease; SARS‐CoV, severe acute respiratory syndrome coronavirus Compound 159 was further scrutinized by investigating the importance of the amide NH, and the effect of the substituent on the benzamide ring (160–164). |
T674 | 2133-2319 | Sentence | denotes | Among them, compounds 163 and 164 exhibited the most potent enzymatic (163: IC50, 0.46 µM; 164: IC50, 1.23 µM) and cell‐based antiviral (163: EC50, 6.0 µM; 164: EC50, 5.2 µM) activities. |
T675 | 2320-2383 | Sentence | denotes | Next, the same group studied the SARs for compound 158 further. |
T676 | 2384-2544 | Sentence | denotes | This led to the discovery of compound 165 with high PLpro inhibitory activity of SARS‐CoV‐1 (IC50, 0.32 µM) and antiviral activity (EC50, 9.1 µM) in Vero cells. |
T677 | 2545-2639 | Sentence | denotes | 199 The mode of action of 165 was found to be a noncovalent, competitive inhibition of PLpro. |
T678 | 2640-2771 | Sentence | denotes | Unlike the previous series, the stereochemistry at the α‐methyl group did not make a significant difference in inhibition of PLpro. |
T679 | 2772-2981 | Sentence | denotes | For example, both (S)‐ and (R)‐methyl inhibitors, 165 (IC50, 0.32 µM; EC50, 9.1 µM and 166 (IC50, 0.56 µM; EC50, 9.1 µM), respectively, shared equipotent inhibitory activity in enzymatic and cell‐based assays. |
T680 | 2982-3052 | Sentence | denotes | Further SARs of 159 and 165 were investigated to improve the activity. |
T681 | 3053-3192 | Sentence | denotes | However, no significant improvement in the activity was observed for the prepared compounds either in the enzymatic or cell‐based bioassay. |
T682 | 3193-3264 | Sentence | denotes | Compounds 167–169 (Figure 36) displayed the best inhibitory activities. |
T683 | 3265-3407 | Sentence | denotes | Especially, the m‐fluoro‐substituted benzamide derivative 168 (IC50, 0.15 µM; EC50, 5.4 µM) showed the best inhibition activity against PLpro. |
T684 | 3408-3464 | Sentence | denotes | It also inhibited SARS‐CoV‐1 in the cell‐based bioassay. |
T685 | 3465-3544 | Sentence | denotes | Both compounds 168 and 169 were metabolically more stable when compared to 167. |
T686 | 3545-3704 | Sentence | denotes | HTS of a chemical library of 25000 molecules identified 170 (Figure 37) as a dual SARS‐CoV‐1 PLpro (IC50, 10.9 µM) and MERS‐CoV PLpro (IC50, 6.2 µM) inhibitor. |
T687 | 3705-3835 | Sentence | denotes | 200 This compound acts via competitive inhibition against MERS‐CoV PLpro, yet via allosteric inhibition against SARS‐CoV‐1 PLpro. |
T688 | 3836-4014 | Sentence | denotes | This compound also exhibited a preference for SARS‐CoV‐1 PLpro and MERS‐CoV PLpro versus two human homologs of the PLpro, ubiquitin C‐terminal hydrolase, (hUCH‐L1) and (hUCH‐L3). |
T689 | 4015-4081 | Sentence | denotes | Figure 37 Broad spectral PLpro inhibitors from different sources. |
T690 | 4082-4178 | Sentence | denotes | PLpro, papain‐like protease; SARS‐CoV, severe acute respiratory syndrome coronavirus Chou et al. |
T691 | 4179-4322 | Sentence | denotes | 201 identified thiopurine (171) and 6‐thioguanine (172) as SARS‐CoV‐1 PLpro inhibitors by the screening of a library containing 160 compounds. |
T692 | 4323-4381 | Sentence | denotes | The thiocarbonyl group was important for PLpro inhibition. |
T693 | 4382-4484 | Sentence | denotes | However, the toxicity of these anticancer agents limits their therapeutic utility as anti‐SARS agents. |
T694 | 4485-4505 | Sentence | denotes | In 2012, Park et al. |
T695 | 4506-4609 | Sentence | denotes | 202 reported a tanshinone derivative 173 as a SARS‐CoV‐1 PLpro inhibitor with an IC50 value of 0.8 µM. |
T696 | 4610-4692 | Sentence | denotes | The same research group also described diarylheptanoids blocking SARS‐CoV‐1 PLpro. |
T697 | 4693-4799 | Sentence | denotes | In particular compound 174 performed as the best inhibitor of SARS‐CoV PLpro with an IC50 value of 4.1 µM. |
T698 | 4800-4879 | Sentence | denotes | An α,β‐unsaturated carbonyl functionality was crucial for effective inhibition. |
T699 | 4880-5026 | Sentence | denotes | The geranylated flavonoid 175 was another plant‐derived natural product, which displayed SARS‐CoV‐1 PLpro inhibition with an IC50 value of 5.0 µM. |
T700 | 5027-5030 | Sentence | denotes | 203 |
T701 | 5031-5051 | Sentence | denotes | In 2017, Park et al. |
T702 | 5052-5121 | Sentence | denotes | 204 assessed the inhibitory activity of polyphenols isolated from B. |
T703 | 5122-5175 | Sentence | denotes | Papyrifera against SARS‐CoV PLpro and MERS‐CoV PLpro. |
T704 | 5176-5328 | Sentence | denotes | Two of them (176 and 177 Figure 37) displayed moderate inhibition at both SARS‐CoV‐1 PLpro and MERS‐CoV PLpro with a noncompetitive mechanism of action. |
T705 | 5329-5563 | Sentence | denotes | Disulfiram (151; Figure 35) was also reported as a SARS‐CoV‐1 PLpro inhibitor (IC50, 24.1 µM), 205 probably by reacting with the active site cysteine, thereby covalently modifying the enzyme target, as was reported for other targets. |